| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3106311 | Burns | 2008 | 4 Pages |
Abstract
To conclude, this study demonstrated that tigecycline exhibits in vitro activity against clinical isolates of MDR A. baumannii, MRSA, and Enterococcus spp. isolated from burn patients. Tigecycline is a promising therapeutic option for difficult to treat burn infections due to these pathogens.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
F. Timurkaynak, H. Arslan, Ã. Kurt Azap, S. Serin Senger, Ã. BaÅaran, S. Ãzbalikci Karaman, M. Haberal,